pyrvinium has been researched along with Disease Models, Animal in 8 studies
*Disease Models, Animal: Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases. [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (12.50) | 29.6817 |
| 2010's | 3 (37.50) | 24.3611 |
| 2020's | 4 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chong, CR; Downey, AS; Graczyk, TK; Sullivan, DJ | 1 |
| Chandal, N; Mahey, N; Nandanwar, H; Tambat, R; Thakur, KG; Verma, DK | 1 |
| El-Demerdash, E; El-Derany, MO | 1 |
| Hatamipour, M; Jaafari, MR; Sahebkar, A; Shakour, N; Zangui, M | 1 |
| Gupta, K; Kumari, A; Pandey, S; Sen, P; Singh, G; Singh, R | 1 |
| Clark, PE; Lee, E; Love, HD; Moses, HL; Polosukhina, D; Zent, R | 1 |
| Murakoshi, M; Saiki, K; Sato, TN; Urayama, K | 1 |
| Bakhshinyan, D; Bhatia, M; Doble, BW; Garg, N; Hallett, R; Hassell, JA; Lach, B; Mahendram, S; Manoranjan, B; McFarlane, N; Murty, NK; Nolte, SM; Provias, JP; Qazi, MA; Reddy, K; Singh, M; Singh, SK; Subapanditha, M; Venugopal, C; Vijayakumar, T; Vora, P | 1 |
8 other study(ies) available for pyrvinium and Disease Models, Animal
| Article | Year |
|---|---|
Efficacy of pyrvinium pamoate against Cryptosporidium parvum infection in vitro and in a neonatal mouse model.
Topics: Animals; Animals, Newborn; Antiprotozoal Agents; Cell Line; Cryptosporidiosis; Cryptosporidium parvum; Disease Models, Animal; Dose-Response Relationship, Drug; Humans; Mice; Mice, Inbred BALB C; Pyrvinium Compounds; Treatment Outcome | 2008 |
Repurposing Approved Drugs as Fluoroquinolone Potentiators to Overcome Efflux Pump Resistance in Staphylococcus aureus.
Topics: Animals; Anti-Bacterial Agents; Bacterial Proteins; Biofilms; Carrier Proteins; Ciprofloxacin; Disease Models, Animal; Drug Evaluation, Preclinical; Drug Repositioning; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Female; Fluoroquinolones; Humans; Mice; Mice, Inbred BALB C; Molecular Docking Simulation; Multidrug Resistance-Associated Proteins; Norfloxacin; Pyrvinium Compounds; Raloxifene Hydrochloride; Staphylococcal Infections; Staphylococcus aureus | 2021 |
Pyrvinium pamoate attenuates non-alcoholic steatohepatitis: Insight on hedgehog/Gli and Wnt/β-catenin signaling crosstalk.
Topics: Animals; beta Catenin; Diet, High-Fat; Disease Models, Animal; Down-Regulation; Hedgehog Proteins; Liver Cirrhosis; Non-alcoholic Fatty Liver Disease; Protective Agents; Pyrvinium Compounds; Rats; Rats, Sprague-Dawley; Streptozocin; Wnt Proteins; Wnt Signaling Pathway; Zinc Finger Protein GLI1 | 2020 |
Anti-Tumor Efficacy of Pyrvinium Pamoate Nanoliposomes in an Experimental Model of Melanoma.
Topics: Animals; Antineoplastic Agents; Cell Proliferation; Disease Models, Animal; Drug Carriers; Drug Screening Assays, Antitumor; Female; Liposomes; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Nanoparticles; Pyrvinium Compounds; Tumor Cells, Cultured | 2021 |
Wnt/β-Catenin Antagonist Pyrvinium Exerts Cardioprotective Effects in Polymicrobial Sepsis Model by Attenuating Calcium Dyshomeostasis and Mitochondrial Dysfunction.
Topics: Animals; beta Catenin; Calcium; Cardiomyopathies; Coinfection; Cytokines; Disease Models, Animal; Fibrosis; Inflammation Mediators; Male; Mitochondria, Heart; Mitochondrial Permeability Transition Pore; Myocytes, Cardiac; Necrosis; Oxidative Stress; Pyrvinium Compounds; Rats, Wistar; Sepsis; Ventricular Function, Left; Ventricular Pressure; Wnt Signaling Pathway | 2021 |
Pharmacologic Inhibition of β-Catenin With Pyrvinium Inhibits Murine and Human Models of Wilms Tumor.
Topics: Animals; Anthelmintics; beta Catenin; Cell Line, Tumor; Cell Proliferation; Disease Models, Animal; Humans; Mice; Pyrvinium Compounds; Signal Transduction; Transcription, Genetic; Wilms Tumor; Wnt Signaling Pathway | 2017 |
An anthelmintic drug, pyrvinium pamoate, thwarts fibrosis and ameliorates myocardial contractile dysfunction in a mouse model of myocardial infarction.
Topics: Animals; Anthelmintics; Cell Survival; Disease Models, Animal; Fibroblasts; Fibrosis; Male; Mice; Muscle Contraction; Myocardial Infarction; Myocardium; Pyrvinium Compounds | 2013 |
Pyrvinium Targets CD133 in Human Glioblastoma Brain Tumor-Initiating Cells.
Topics: AC133 Antigen; Animals; Antigens, CD; Antineoplastic Agents; Brain Neoplasms; Cell Proliferation; Cell Self Renewal; Disease Models, Animal; Gene Expression; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Knockdown Techniques; Gene Regulatory Networks; Glioblastoma; Glycoproteins; Humans; Neoplastic Stem Cells; Peptides; Prognosis; Pyrvinium Compounds; Signal Transduction; Spheroids, Cellular; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2015 |